Thioredoxin as a biomarker for graft rejection in lung transplant recipients

Biomarkers

Volumn 13, Issue 5, 2008, Pages 486-495

  Patel, Jawaharlal M ^a,b   Hu, Hanbo ^a   Lu, Li ^a   Deem, Amy ^a   Akindipe, Olufemi ^a   Brantly, Mark ^a   Block, Edward R ^a,b   Antony, Veena B ^a   Baz, Maher A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

BAL cell differential; Graft rejection; Lung transplant; Thioredoxin

Indexed keywords

AZATHIOPRINE; PREDNISONE; RAPAMYCIN; TACROLIMUS; THIOREDOXIN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BRONCHIECTASIS; CELL LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; EOSINOPHIL COUNT; FEMALE; FIBROSING ALVEOLITIS; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIA; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG SARCOIDOSIS; LUNG TRANSPLANTATION; LYMPHOCYTE COUNT; MACROPHAGE; MALE; NEUTROPHIL COUNT; PATHOPHYSIOLOGY; POSTOPERATIVE CARE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TRANSBRONCHIAL BIOPSY;

ADULT; AGED; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CELL DIFFERENTIATION; FEMALE; GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; REFERENCE STANDARDS; THIOREDOXINS;

CYTOMEGALOVIRUS; RATTUS;

EID: 47949133009     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500802061822     Document Type: Article

References (40)

1. Bando, K., Paradis, IL, Komatsu, K., Konishi, H., Matsushima, M., Keenan, R., Hardesty, RL, Armitage, JM and Griffith, BP. (1995) Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation. Journal of Thoracic & Cardiovascular Surgery, 109, pp. 49-59.
2. Baz, MA, Layish, DT, Govert, JA, Howell, DN, Lawrence, CM, Davis, RD and Tapson, VF. (1996) Diagnostic yield of bronchoscopies after isolated lung transplantation. Chest, 110, pp. 84-88.
3. Bertini, R., Zack Howard, OM, Dong, HF, Oppenheim, JJ, Bizzarri, C., Sergi, R., Caselli, G., Pagliei, S., Romines, B., Wilshire, JA, Mengozzi, M., Nakamura, H., Yodoi, J., Pekkari, K., Gurunath, R., Holmgren, A., Herzenberg, LA and Ghezzi, P. (1999) Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. Journal of Experimental Medicine, 189, pp. 1783-1789.
4. Billiet, L., Furman, C., Larigauderie, G., Copin, C., Brand, K., Fruchart, JC and Rouis, M. (2005) Extracellular human thioredoxin-1 inhibits lipopolysaccharide-induced interleukin-1β; expression in human monocyte-derived macrophages. Journal of Biological Chemistry, 280, pp. 40310-40318.
5. Briscoe, DM, Alexander, SI and Lichtman, AH. (1998) Interaction between T lymphocytes and endothelial cells in allograft rejection. Current Opinions in Immunology, 10, pp. 525-531.
6. Burke-Gaffney, A., Callister, ME and Nakamura, H. (2005) Thioredoxin: friend or foe in human disease?. Trends in Pharmacological Sciences, 26, pp. 398-404.
7. Callister, ME, Burke-Gaffney, A., Quinlan, GJ, Quinlan, GJ, Nicholson, AG, Florio, R., Nakamura, H., Yodoi, J. and Evans, TW. (2006) Extracellular thioredoxin levels are increased in patients with acute lung injury. Thorax, 61, pp. 521-527.
8. Calvin, SH, Ng, SW, Ahmed, AA and Anthony, PCY. (2006) Inflammatory response to pulmonary ischemia-reperfusion injury. Surgery Today, 36, pp. 205-214.
9. Chatila, WM, Furukawa, S., Gaughan, JP and Criner, GJ. (2003) Respiratory failure after lung transplantation. Chest, 123, pp. 165-173.
10. Christie, JD, Bavaria, JE, Palevsky, HI, Litzky, L., Blumenthal, NP, Kaiser, LR and Kotloff, RM. (1998) Primary graft failure following lung transplantation. Chest, 114, pp. 51-60.
11. Cottini, SR, Lerch, N., Treggiari, MM, Spiliopoulos, A., Nicod, L. and Ricou, B. (2006) Risk factors for reperfusion injury after lung transplantation. Intensive Care Medicine, 32, pp. 557-563.
12. Hoyos, De, Patterson, GA, Maurer, JR, Ramirez, JC and Miller, JD. (1992) Pulmonary transplantation: Early and late results. Journal of Thoracic & Cardiovascular Surgery, 103, pp. 295-306.
13. DeMeo, DL and Ginns, LC. (2001) Clinical status of lung transplantation. Transplantation, 72, pp. 1713-1724.
14. de Perrot, M., Liu, M., Waddell, TK and Keshavjee, S. (2003) Ischemia-reperfusion-induced lung injury. American Journal of Respiratory & Critical Care Medicine, 167, pp. 490-511.
15. Ghosh, S., May, MJ and Kopp, EB. (1998) NF-(B and Rel proteins: evolutionarily conserved mediators of immune responses. Annual Review of Immunology, 16, pp. 225-260.
16. Gromer, S., Urig, S. and Becker, K. (2004) The thioredoxin system: From science to clinic. Medicinal Research Reviews, 24, pp. 40-89.
17. Hirt, SW, You, XM, Moller, F., Boeke, K., Kretschmar, J., Starke, M., Steinmann, J. and Wottge, HU. (1999) The influence of ischemia on the severity of chronic rejection in a rat lung transplant model. Transplantation Proceedings, 31, pp. 189-190.
18. Holmgren, A. (1985) Thioredoxin. Annual Review of Biochemistry, 54, pp. 237-271.
19. Hu, H., Lu, L., Mu, W., Block, ER and Patel, JM. (2007) Priming donor lungs with thioredoxin attenuates allograft injury in a rat model of lung transplantation. American Journal of Respiratory & Critical Care Medicine, 175, p. A378.
20. King, RC, Binns, O., Rodriguez, F., Kanithanon, RC, Daniel, TM, Spotniz, WD, Tribble, CG and Kron, IL. (2000) Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Annals of Thoracic Surgery, 69, pp. 1681-1685.
21. Mathur, A., Baz, M., Staples, ED, Bonnell, M., Speckman, JM, Hess Jr, PJ, Klodell, CT, Knauf, DG, Moldawer, LL and Beaver, TM. (2006) Cytokine profile after lung transplantation: Correlation with allograft injury. Annals of Thoracic Surgery, 81, pp. 1844-1850.
22. Maurice, MM, Nakamura, H., van der Voort, EA, Van Vliet, AI, Staal, FJ, Tak, PP, Breedveld, FC and Verweij, CL. (1997) Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cell in rheumatoid arthritis. Journal of Immunology, 158, pp. 1458-1465.
23. Meddeloff, EN, Meyers, BF, Sundt, TM, Guthrie, TJ, Sweet, SC, Morena, M de la, Shapiro, S., Balzer, DT, Trulock, EP, Lunch, JP, Pasque, MK, Cooper, JD, Huddleston, CB and patterson, GA. (2002) Lung transplantation for pulmonary vascular disease. Annals of Thoracic Surgery, 73, pp. 209-217.
24. Nakamura, H., De Rosa, S., Roederer, M., Anderson, MT, Dubs, JG, Yodoi, J., Holmgren, A. and Herzenberg, LA. (1996) Elevation of plasma thioredoxin levels in HIV-infected individuals. International Immunology, 8, pp. 603-611.
25. Nordberg, J. and Arner, ES. (2001) Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radical Biology & Medicine, 31, pp. 1287-1312.
26. Okubo, K., Kosaka, S., Isowa, N., Hirata, T., Hitomi, S., Yodoi, J., Nakano, M. and Wada, H. (1997) Amelioration of ischemia-reperfusion injury by human thioredoxin in rabbit lung. Journal of Thoracic & Cardiovascular Surgery, 113, pp. 1-9.
27. Nakamura, H., Herzenberg, LA, Bai, J., Araya, S., Kondo, N., Mishinaka, Y., Herzenberg, LA and Yodoi, J. (2001) Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxix. Proceedings of the National Academy of Science USA, 98, pp. 15143-15148.
28. Patel, JM, Chen, S. and Block, ER. (2001) Thioredoxin expression is increased after lung transplantation in rats. American Journal of Respiratory & Critical Care Medicine, 163, p. A333.
29. Pierre, AF, DeCampos, KN, Liu, M., Edwards, V., Slutsky, AS and Keshavjeee, S. (1998) Rapid reperfusion causes stress failure in ischemic rat lung. Journal of Thoracic & Cardiovascular Surgery, 116, pp. 932-942.
30. Pober, JS and Cotran, RS. (1990) The role of endothelial cells in inflammation. Transplantation, 50, pp. 537-544.
31. Powis, G., Briehl, M. and Oblong, J. (1995) Redox signalling and control of cell growth and death. Pharmacology & Therapeutics, 68, pp. 149-173.
32. Rancourt, RC, Lee, RL, O'Neill, H., Accurso, FJ and White, CW. (2007) Reduced thioredoxin increases proinflammatory cytokines and neutrophil influx in rat airways: Modulation by airway mucus. Free Radical Biology & Medicine, 42, pp. 1441-1453.
33. Schenk, H., Vogt, M., Droge, W. and Schulze-Osthoff, K. (1996) Thioredoxin as a potent costimulus of cytokine expression. Journal of Immunology, 156, pp. 765-771.
34. Siebenlist, U., Franzoso, G. and Brown, K. (1994) Structure, regulation and function of NFκB. Annual Review of Cell Biology, 10, pp. 405-455.
35. Takagi, Y., Mitsui, A., Nishiyama, A., Nozaki, K., Sono, H., Gon, Y., Hashimoto, N. and Yodoi, J. (1999) Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proceedings of the National Academy of Science USA, 96, pp. 4131-4136.
36. Trulock, EP. (1997) Lung transplantation. American Journal of Respiratory & Critical Care Medicine, 155, pp. 789-818.
37. Wada, H., Muro, K., Hirata, T., Yodoi, J. and Hitomi, S. (1995) Rejection and expression of thioredoxin in transplanted canine lung. Chest, 108, pp. 810-814.
38. Yousem, SA, Berry, GJ, Cagle, PT, Chamberlain, D., Husain, AN, Hruban, RH, Marchevsky, A., Ohori, NP, Ritter, J., Stewart, S. and Tazelaar, HD. (1996) Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung rejection study group. Journal of Heart & Lung Transplantation, 15, pp. 1-15.
39. Zhang, JL, Li, YD, Patel, JM and Block, ER. (1998) Thioredoxin overexpression prevents NO-induced reduction of NO synthase activity in lung endothelial cells. American Journal of Physiology Lung Cellular & Molecular Physiology, 275, pp. L288-L293.
40. Zhang, JL, Velsor, LW, Patel, JM and Block, ER. (1999) Nitric oxide-induced reduction of lung cell and whole lung thioredoxin expression is regulated by NFκB. American Journal of Physiology Lung Cellular & Molecular Physiology, 277, pp. L787-L793.